TwinBeech Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.6M | Buy |
79,286
+26,185
| +49% | +$13.7M | 0.94% | 24 |
|
|
2025
Q1 | $33.7M | Buy |
53,101
+27,964
| +111% | +$17.7M | 0.61% | 44 |
|
|
2024
Q4 | $17.9M | Sell |
25,137
-20,730
| -45% | -$14.8M | 0.31% | 108 |
|
|
2024
Q3 | $48.2M | Buy |
+45,867
| New | +$48.2M | 0.92% | 18 |
|
|
2024
Q2 | – | Sell |
-21,013
| Closed | -$20.2M | – | 752 |
|
|
2024
Q1 | $20.2M | Buy |
+21,013
| New | +$20.2M | 0.42% | 68 |
|
|
2023
Q4 | – | Sell |
-248
| Closed | -$204K | – | 869 |
|
|
2023
Q3 | $204K | Sell |
248
-20,350
| -99% | -$16.7M | ﹤0.01% | 599 |
|
|
2023
Q2 | $14.8M | Buy |
20,598
+6,922
| +51% | +$4.97M | 0.29% | 108 |
|
|
2023
Q1 | $11.2M | Buy |
+13,676
| New | +$11.2M | 0.23% | 136 |
|
|
2020
Q1 | – | Sell |
-9,507
| Closed | -$3.57M | – | 435 |
|
|
2019
Q4 | $3.57M | Buy |
+9,507
| New | +$3.57M | 1.03% | 14 |
|